BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · IEX Real-Time Price · USD
26.19
+0.26 (1.00%)
At close: Jul 19, 2024, 4:00 PM
26.07
-0.12 (-0.46%)
Pre-market: Jul 20, 2024, 9:27 AM EDT
BridgeBio Pharma Market Cap
BridgeBio Pharma has a market cap or net worth of $4.90 billion as of July 22, 2024. Its market cap has increased by 79.62% in one year.
Market Cap
4.90B
Enterprise Value
6.11B
1-Year Change
79.62%
Ranking
Category
Stock Price
$26.19
Market Cap Chart
Since June 27, 2019, BridgeBio Pharma's market cap has increased from $3.17B to $4.90B, an increase of 54.69%. That is a compound annual growth rate of 8.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 4.90B | -30.22% |
| Dec 29, 2023 | 7.02B | 516.54% |
| Dec 30, 2022 | 1.14B | -53.60% |
| Dec 31, 2021 | 2.45B | -71.84% |
| Dec 31, 2020 | 8.72B | 101.23% |
| Dec 31, 2019 | 4.33B | 36.71% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nuvalent | 5.15B |
| Doximity | 5.12B |
| PACS Group | 5.04B |
| Select Medical Holdings | 4.96B |
| Merit Medical Systems | 4.96B |
| CRISPR Therapeutics AG | 4.77B |
| TransMedics Group | 4.76B |
| Apellis Pharmaceuticals | 4.61B |